Bredesen J E, Kierulf P
Br J Clin Pharmacol. 1984 Nov;18(5):779-84. doi: 10.1111/j.1365-2125.1984.tb02542.x.
Highly purified serum albumin did not bind either disopyramide (DP) or mono-N-dealkyldisopyramide (MND). The unbound fraction of DP and MND in highly purified serum alpha 1-acid glycoprotein (AAG) at 0.5 g/l was 57 and 62 and at 2.0 g/l 19 and 30% respectively. Unbound DP and MND were measured in spiked plasma (10 mumol/l of DP or MND), from 60 patients, having AAG concentrations varying from 0.4 to 3.0 g/l. Unbound drug varied from 13 to 58 and from 24 to 62% for DP and MND, respectively, and was inversely related to the plasma concentration of AAG (r = -0.9016, r = -0.9157). A linear relationship was found between the binding ratio (moles bound divided by moles unbound) and the plasma concentration of AAG for both DP (r = 0.9199) and MND (r = 0.9270), whereas no relationship was found between the binding ratios of DP or MND and the plasma concentrations of total protein, albumin, haptoglobin, alpha 1-antitrypsin or the immunoglobulins IgG, IgA or IgM. In patients on DP maintenance therapy, a linear relationship was found between percent unbound DP and the plasma concentration of DP in samples with similar AAG concentrations. Furthermore, a linear relationship was found between the binding ratio of DP and the plasma concentration of AAG in samples with similar DP concentrations. The present findings support the concept that AAG is the major serum protein responsible for the binding of DP and MND.
高度纯化的血清白蛋白既不与丙吡胺(DP)结合,也不与单-N-去烷基丙吡胺(MND)结合。在浓度为0.5 g/l的高度纯化血清α1-酸性糖蛋白(AAG)中,DP和MND的游离分数分别为57%和62%;在浓度为2.0 g/l时,分别为19%和30%。对60名AAG浓度在0.4至3.0 g/l之间的患者的加标血浆(10 μmol/l的DP或MND)中的游离DP和MND进行了测定。DP和MND的游离药物分别在13%至58%和24%至62%之间变化,且与AAG的血浆浓度呈负相关(r = -0.9016,r = -0.9157)。对于DP(r = 0.9199)和MND(r = 0.9270),均发现结合比(结合的摩尔数除以未结合的摩尔数)与AAG的血浆浓度之间存在线性关系,而未发现DP或MND的结合比与总蛋白、白蛋白、触珠蛋白、α1-抗胰蛋白酶或免疫球蛋白IgG、IgA或IgM的血浆浓度之间存在关系。在接受DP维持治疗的患者中,在AAG浓度相似的样本中,游离DP百分比与DP的血浆浓度之间发现了线性关系。此外,在DP浓度相似的样本中,DP的结合比与AAG的血浆浓度之间也发现了线性关系。目前的研究结果支持了AAG是负责DP和MND结合的主要血清蛋白这一概念。